Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
AVENG LTD. RC 25 | UG8 | 21. nov 2024 | 0.55 | 0.00 |
Avensia | 5IY | 21. nov 2024 | 0.62 | -2.52 |
Avery Dennison Corporation | AV3 | 21. nov 2024 | 187.00 | +0.54 |
Avex Inc. | AX8 | 21. nov 2024 | 9.05 | +1.12 |
AVI LTD (UNSP.ADR)/5 | IZ60 | 21. nov 2024 | 28.00 | +0.72 |
Avi Ltd. | IZ6 | 21. nov 2024 | 5.75 | +0.88 |
Avia Avian Tbk PT | P2C | 21. nov 2024 | 0.03 | 0.00 |
Aviat Networks, Inc. | HSD1 | 21. nov 2024 | 13.70 | +0.74 |
AVICHINA | AVT | 21. nov 2024 | 0.47 | +0.43 |
Avid Bioservices, Inc. | TEHP | 21. nov 2024 | 11.50 | 0.00 |
Avingtrans plc | DZR | 21. nov 2024 | 4.56 | +0.44 |
Avino Silver & Gold Mines Ltd. | GV6 | 21. nov 2024 | 1.06 | +1.44 |
Avio S.p.A | 2ZP | 21. nov 2024 | 12.22 | +2.86 |
Avis Budget Group, Inc. | CUCA | 21. nov 2024 | 93.12 | -1.19 |
Avista Corporation | AV6 | 21. nov 2024 | 36.40 | -0.55 |
AVITA Medical Inc | 51KB | 21. nov 2024 | 2.44 | +0.83 |
Avita Therapeutics, Inc. | 51KA | 21. nov 2024 | 12.20 | +1.67 |
AVIVA PLC LS-,33 | GU81 | 21. nov 2024 | 5.80 | -0.85 |
AVIVA PLC SPONS.ADR/2 | GU80 | 21. nov 2024 | 11.30 | -0.88 |
Avnet, Inc. | VNI | 21. nov 2024 | 50.00 | +1.63 |
Avon Rubber plc | 1OK | 21. nov 2024 | 14.40 | -2.70 |
Avricore Health Inc. | 8VP1 | 21. nov 2024 | 0.04 | 0.00 |
Avrupa Minerals Ltd | 8AMA | 21. nov 2024 | 0.00 | 0.00 |
AVTECH Sweden B | 8QL | 21. nov 2024 | 0.30 | +3.81 |
Awakn Life Sciences Corp | 954 | 21. nov 2024 | 0.06 | -13.99 |
AWILCO DRILLING PLC(SNDR) | 0AI1 | 21. nov 2024 | 1.85 | 0.00 |
Awilco LNG | AWQ | 21. nov 2024 | 0.32 | -1.38 |
Axa | AXAA | 21. nov 2024 | 34.00 | +0.59 |
AXA | AXA | 21. nov 2024 | 34.11 | +0.62 |
Axactor | 2LJ | 21. nov 2024 | 0.29 | -0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.